Ritonavir is an antiretroviral medication used as an active pharmaceutical ingredient in combination therapies for HIV/AIDS. It functions as a protease inhibitor and is primarily utilized to enhance the potency of other protease inhibitors in highly active antiretroviral therapy (HAART).
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Ritonavir?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Istradefylline
pharmaceutical raw material
Sodium 1-glycerophosphate
pharmaceutical raw material
Minodronic acid monohydrate
pharmaceutical raw material
Pizotyline
pharmaceutical raw material
The international HS code for Ritonavir (CAS 155213-67-5) is 2934.10.
2934.10
2934 10 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
NCDNCNXCDXHOMX-XGKFQTDJSA-N
CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
Sourcing Ritonavir?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.